ID: ALA2088248

Max Phase: Preclinical

Molecular Formula: C18H11N3OS2

Molecular Weight: 349.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1c2sc3ccccc3c2nc2n1N=C(c1ccccc1)CS2

Standard InChI:  InChI=1S/C18H11N3OS2/c22-17-16-15(12-8-4-5-9-14(12)24-16)19-18-21(17)20-13(10-23-18)11-6-2-1-3-7-11/h1-9H,10H2

Standard InChI Key:  YWTLMWHKFCHPIJ-UHFFFAOYSA-N

Associated Targets(Human)

Cyclooxygenase-2 13999 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 349.44Molecular Weight (Monoisotopic): 349.0344AlogP: 3.97#Rotatable Bonds: 1
Polar Surface Area: 47.25Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.53CX LogD: 4.53
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.49Np Likeness Score: -1.59

References

1. Basile L, Alvarez S, Blanco A, Santagati A, Granata G, Di Pietro P, Guccione S, Muñoz-Fernández MÁ..  (2012)  Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: synthesis, biological evaluation, and docking studies.,  57  [PMID:23047231] [10.1016/j.ejmech.2012.09.005]

Source